<DOC>
	<DOC>NCT03103256</DOC>
	<brief_summary>The purpose of this study is to determine superiority of YHP1701 comparing to each monotherapy in patient with hypertension and primary hypercholesterolemia.</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Efficacy and Safety of YHP1701</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Both man and woman who is over 19 years old Patient with dyslipidemia and hypertension sSBP difference is ≥20 mmHg or sDBP difference is ≥10 mmHg A history of cardiovascular disease Rhabdomyolysis, myopathy Hypertension or hypercholesterolemia due to secondary causes Uncontrolled diabetes Evidence of hepatic or renal disease</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>